Comparing Articular Noise and Its Perception Between Two Different Types of Individualized Total Knee Arthroplasty
NCT ID: NCT07030049
Last Updated: 2025-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
210 participants
INTERVENTIONAL
2025-09-30
2028-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bone Mineral Density Changes Under Two Tibial Components in Total Knee Arthroplasty
NCT01764984
Conventional Versus Patient-specific Instruments in Total Knee Arthroplasty
NCT02993016
Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties. A Trial Evaluating Early Component Migration by RSA and Patient Reported Outcome.
NCT01966848
Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?
NCT00492973
Genicular Radiofrequency Ablation Following Total Knee Arthroplasty
NCT05283889
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recent advancements have shifted medicine from standardised approaches to personalised or precision medicine, tailoring treatments and decisions for individual patients based on their specific responses and risk factors. Individualized TKA adapts features to align with pre-arthritic anatomy and restore native movement, often utilising various tools. Recent studies on individualized TKA have demonstrated promising outcomes regarding personalised coronal alignment targets, correction of extra-articular deformities, intra-operative workflow, accommodation of the third compartment, and patient satisfaction rates.
This study will compare a posterior-stabilised (PS) and a cruciate-retaining (CR) individualized TKA implant. The PS implant is selected for patients with a damaged or a non-functional posterior cruciate ligament. In this case, the ligament is removed and substituted with a post-cam mechanism that aids femoral rollback during knee flexion and avoids anterior femoral subluxation. In contrast, the CR implant design can be selected for patients with an intact and functional posterior cruciate ligament. In this case, the ligament is retained, allowing it to guide femoral rollback and prevent anterior subluxation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PS-group
Individualized PS TKA
Postero-stabilized total knee replacement for knee osteoarthritis
Total knee arthroplasty in which the osteoarthritic knee is replaced with a postero-stabilized total knee replacement. The postero-stabilized TKA consists of a femoral component with a build-in cam mechanism and a tibial component with a post-mechanism.
CR-group
Individualized CR TKA
Cruciate-retaining total knee replacement for knee osteoarthritis
Total knee arthroplasty in which the osteoarthritic knee is replaced with a cruciate-retaining total knee replacement. The cruciate-retaining TKA consists of a femoral component and a tibial component that leaves the posterior cruciate ligament intact.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Postero-stabilized total knee replacement for knee osteoarthritis
Total knee arthroplasty in which the osteoarthritic knee is replaced with a postero-stabilized total knee replacement. The postero-stabilized TKA consists of a femoral component with a build-in cam mechanism and a tibial component with a post-mechanism.
Cruciate-retaining total knee replacement for knee osteoarthritis
Total knee arthroplasty in which the osteoarthritic knee is replaced with a cruciate-retaining total knee replacement. The cruciate-retaining TKA consists of a femoral component and a tibial component that leaves the posterior cruciate ligament intact.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* receiving elective primary TKA as a treatment for osteoarthritis
* with an intact and functional posterior cruciate ligament
* with no previous knee surgery, on the ipsi- or contra-lateral knee
* who signed the informed consent and are willing to comply with the protocol requirements based on the investigator's judgment.
* affiliated with a social security scheme
* with an ability to answer questionnaires and to communicate freely in French.
Exclusion Criteria
* that underwent previous knee surgery, except arthroscopic surgery, on their ipsilateral knee
* with coronal deformities \>20°
* that are pregnant
* any contraindication mentioned in the instructions for use of the medical devices under investigation
* with protected status under articles L1121-6, LL121-8 and L1122-2 of the French Public Health Code
* with other significant disease or disorder which, in the opinion of the investigating surgeon, may put the participant at risk because of participation in the study, or may influence the result of the study
* who cannot comply with the protocol requirements based on the investigator's judgment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ProSurg
UNKNOWN
Clinique Trenel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-A00647-42
Identifier Type: OTHER
Identifier Source: secondary_id
25.01072.000461
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.